Cathepsin L Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Cathepsin L antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Cathepsin L |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) Paraffin, ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Cathepsin L Polyclonal Antibody detects endogenous levels of Cathepsin L protein. Cathepsin L1 encoded by CTSL1 is a lysosomal cysteine proteinase that plays a major role in intracellular protein catabolism. Its substrates include collagen and elastin, as well as alpha-1 protease inhibitor, a major controlling element of neutrophil elastase activity. The encoded protein has been implicated in several pathologic processes, including myofibril necrosis in myopathies and in myocardial ischemia, and in the renal tubular response to proteinuria. This protein, which is a member of the peptidase C1 family, is a dimer composed of disulfide-linked heavy and light chains, both produced from a single protein precursor. Multiple alternativ |
| Immunogen | Immunogen: Synthesized peptide derived from the internal region of human Cathepsin L |
| Other Names | [Rabbit Cathepsin L; CTSL1; Cathepsin L1; Major excreted protein; MEP] |
| Gene, Accession # | [CTSL], Gene ID: 1514, NCBI: NP_001244900.1, UniProt: P07711 |
| Catalog # | MBS9703518 |
| Price | $130, $220, $325 |
| Order / More Info | Cathepsin L Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies